Journal of Hepatology
Volume 48, Issue 4 , Pages 666-675, April 2008

The function of serotonin within the liver

  • Richard G. Ruddell

      Affiliations

    • Hepatic Fibrosis Group, The Queensland Institute of Medical Research, PO Royal Brisbane and Women’s Hospital, Brisbane, Qld 4029, Australia
    • Corresponding Author InformationCorresponding author. Tel.: +61 7 33620175; fax: +61 7 33620191.
  • ,
  • Derek A. Mann

      Affiliations

    • Liver Group, Institute of Cellular Medicine, University of Newcastle, Newcastle upon Tyne NE2 4HH, UK
  • ,
  • Grant A. Ramm

      Affiliations

    • Hepatic Fibrosis Group, The Queensland Institute of Medical Research, PO Royal Brisbane and Women’s Hospital, Brisbane, Qld 4029, Australia

published online 28 January 2008.

Associate Editor: J. Bosch

Serotonin or 5-hydroxytryptamine (5-HT) is known to regulate several key aspects of liver biology and these functions include hepatic blood flow, innervation and wound healing. Given the importance of these functions it is surprising that relatively little time has been dedicated to studying the precise function and mechanisms of serotonin within the liver. Here we describe what is known about serotonin and the liver and those receptor types that mediate the observed effects with an aim to stimulating new interest in the field of serotonin and liver biology.

Abbreviations: 5-HIAA, 5-hydroxyindoleacetaldehyde, 5-HT, 5-hydroxytryptamine, ANS, autonomic nervous system, BDEC, bile duct epithelial cell, CNS, central nervous system, ECM, extracellular matrix, ERK1/2, extracellular regulated kinase 1/2, GI, gastrointestinal, HSC, hepatic stellate cell, HCC, hepatocellular carcinoma, MAO, monoamine oxidase, PHx, partial hepatectomy, SEC, sinusoidal endothelial cell, SERT, serotonin transporter, SMV, superior mesenteric vein, SSRI, selective serotonin reuptake inhibitor

Keywords: 5-Hydroxytryptamine/serotonin, Liver, Innervation, Haemodynamics, Wound healing

 

 The authors declare that they do not have anything to disclose regarding funding from industries or conflict of interest with respect to this manuscript.

PII: S0168-8278(08)00050-0

doi:10.1016/j.jhep.2008.01.006

Journal of Hepatology
Volume 48, Issue 4 , Pages 666-675, April 2008